MODUPE JAMES: Open Payments
NPI 1801332853 · ROSENBERG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$917 in 58 payments from 11 companies in 2025. Trend: 2023 $733 · 2024 $526 · 2025 $917
Food & beverage: $917
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 16 | $246 |
| Teva Pharmaceuticals USA, Inc. | 14 | $192 |
| Neurocrine BioSciences, Inc. | 6 | $154 |
| Vanda Pharmaceuticals Inc. | 4 | $70 |
| Alkermes, Inc. | 4 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Corium, LLC | 5 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $46 |
| Luye Pharma (USA) Ltd. | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: COBENFY, INGREZZA, UZEDY, FANAPT, ARISTADA, AUSTEDO XR, ABILIFY ASIMTUFII, Azstarys.
Industry payments across TX — which companies pay providers there.
